Metabolic Acidosis and Cardiovascular Disease in CKDPlain-Language Summary

Metabolic Acidosis and Cardiovascular Disease in CKDPlain-Language Summary

Rationale & Objective: Metabolic acidosis related to chronic kidney disease (CKD) is associated with an accelerated decline in glomerular filtration rate (GFR) and the development of end-stage kidney disease. Whether metabolic acidosis is associated with cardiovascular (CV) events in patient...

Full description

Bibliographic Details
Main Authors:	David Collister, Thomas W. Ferguson, Susan E. Funk, Nancy L. Reaven, Vandana Mathur, Navdeep Tangri
Format:	Article
Language:	English
Published:	Elsevier 2021-09-01
Series:	Kidney Medicine
Subjects:	Cardiovascular chronic kidney disease CKD heart failure major adverse cardiovascular events metabolic acidosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590059521001151

Similar Items

Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort StudyPlain Language Summary
by: Nancy L. Reaven, et al.
Published: (2023-05-01)

Association of body mass index with the development of metabolic acidosis in patients with chronic kidney disease
by: Vandana Mathur, et al.
Published: (2023-12-01)

Serum Bicarbonate and Graft and Patient Outcomes Among Kidney Transplant Recipients: A Retrospective Cohort Study Evaluating Changes in Serum Bicarbonate Over TimePlain-Language Summary
by: Vandana Mathur, et al.
Published: (2023-01-01)

Impact of a Medical Fitness Model on Incident Major Adverse Cardiovascular Events: A Prospective Cohort Study of 11 000 Members
by: Ranveer Brar, et al.
Published: (2024-04-01)

Excess Risk of Major Adverse Cardiovascular and Kidney Events after Acute Kidney Injury following Living Donor Liver Transplantation
by: Yi-Chia Chan, et al.
Published: (2022-05-01)

Acute Kidney Injury and Long-Term Risk for Cardiovascular Events in Patients after Kidney Transplantation
by: Ruth Rahamimov, et al.
Published: (2019-09-01)

Standardized risk-stratified cardiac assessment and early posttransplant cardiovascular complications in kidney transplant recipients
by: Silvie Rajnochova Bloudickova, et al.
Published: (2024-01-01)

Effects of secukinumab and ixekizumab on major adverse cardiovascular events in patients with psoriasis: a meta-analysis of randomized controlled trials
by: Yonghong Zhang, et al.
Published: (2024-03-01)

Comparative efficacy of pharmacological agents on reducing the risk of major adverse cardiovascular events in the hypertriglyceridemia population: a network meta-analysis
by: Yan-yan Qi, et al.
Published: (2021-01-01)

Age and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: a post hoc analysis of the randomized PATH-PCI trial
by: Ying Pan, et al.
Published: (2023-12-01)

Cardiovascular adverse reactions associated with escitalopram in patients with underlying cardiovascular diseases: a systematic review and meta-analysis
by: Kenichi Kimura, et al.
Published: (2023-09-01)

Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin
by: Imane Achir Alispahic, et al.
Published: (2024-03-01)

Performance of Cardiovascular Risk Prediction Models in Korean Patients With New‐Onset Rheumatoid Arthritis: National Cohort Study
by: Jae Hyun Kim, et al.
Published: (2023-11-01)

Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
by: Resham L. Gurung, et al.
Published: (2024-02-01)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
by: Meifan Zheng, et al.
Published: (2020-06-01)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
by: Michael J. Cutler, et al.
Published: (2022-12-01)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
by: Jung‐Chi Hsu, et al.
Published: (2023-02-01)

Statins: targeting cardiovascular disease
by: Farouk Mamdoo, et al.
Published: (2017-04-01)

Platelet reactivity in stable cardiovascular patients with chronic kidney disease
by: Thomas A. Mavrakanas, et al.
Published: (2018-07-01)

Clinical Considerations for Cannabis Use and Cardiovascular Health
by: Ruba Sajdeya, et al.
Published: (2022-09-01)

Prediabetes increases the risk of major limb and cardiovascular events
by: Jung-Chi Hsu, et al.
Published: (2023-12-01)

Risk Factors of Secondary Cardiovascular Events in a Multi-Ethnic Asian Population with Acute Myocardial Infarction: A Retrospective Cohort Study from Malaysia
by: Sophia Rasheeqa Ismail, et al.
Published: (2023-06-01)

Dialysate Magnesium and Coronary Artery Calcification, Bone Mineral Density, and Cramping in Maintenance Hemodialysis: A Quasi-experimental StudyPlain-Language Summary
by: Praopilad Srisuwarn, et al.
Published: (2022-02-01)

Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis
by: Christof Aigner, et al.
Published: (2019-05-01)

Prognostic Value of Exercise Capacity in Kidney Transplant Candidates
by: Sean Tan, et al.
Published: (2022-06-01)

Combined with ticagrelor, 50 mg aspirin daily can reduce bleeding events without increasing ischemic risk compared with 75–100 mg aspirin daily in coronary artery disease patients: insights from the TIFU (Ticagrelor in Fuwai Hospital) study
by: Jiannan Li, et al.
Published: (2020-08-01)

Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups
by: Georg Gelbenegger, et al.
Published: (2019-11-01)

Association of plasma angiogenin with risk of major cardiovascular events in type 2 diabetes
by: Gurung, Resham L., et al.
Published: (2024)

Erectile Dysfunction Is a Hallmark of Cardiovascular Disease: Unavoidable Matter of Fact or Opportunity to Improve Men’s Health?
by: Dimitri Yannas, et al.
Published: (2021-05-01)

Objective Sleep Efficiency Predicts Cardiovascular Disease in a Community Population: The Sleep Heart Health Study
by: Bin Yan, et al.
Published: (2021-04-01)

Predicting Major Adverse Cardiovascular Events Following Carotid Endarterectomy Using Machine Learning
by: Ben Li, et al.
Published: (2023-10-01)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
by: Zhihao Chen, et al.
Published: (2018-11-01)

Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016
by: Esben Skov Jensen, et al.
Published: (2021-12-01)

Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease
by: Wojciech Knop, et al.
Published: (2021-10-01)

Reduction of Major Adverse Cardiovascular Events (MACE) after Bariatric Surgery in Patients with Obesity and Cardiovascular Diseases: A Systematic Review and Meta-Analysis
by: Andryanto Sutanto, et al.
Published: (2021-10-01)

The impact of diabetes mellitus on the outcome of troponin-positive patients with non-obstructive coronary arteries
by: Fabienne Kreimer, et al.
Published: (2024-02-01)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
by: Han N, et al.
Published: (2017-11-01)

Higher docosahexaenoic acid levels lower the protective impact of eicosapentaenoic acid on long-term major cardiovascular events
by: Viet T. Le, et al.
Published: (2023-08-01)

Major cardiovascular events under biologic psoriasis therapies: a 19-year real-world analysis of FAERS data
by: Lingqing Ding, et al.
Published: (2024-02-01)

Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease
by: Susanna R. Stevens, et al.
Published: (2022-08-01)